Revenue, 2025
USD 15.63
Forecast Year, 2034
USD 32.83 Bn
CAGR, 2025 - 2034
8.60%
Report Coverage
Worldwide
The global endocrine testing market, valued at USD 15.63 billion in 2025, is projected to reach USD 32.83 billion by 2034, expanding at a CAGR of 8.6%, driven by rising hormonal disorders, advanced diagnostics, and growing healthcare awareness.
Endocrine Testing Market Size Analysis
Endocrine Testing Market Size By Test Type 2025 to 2034 (USD Billion)
| Test Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Estradiol (E2) Test | 0.20 | 0.22 | 0.24 | 0.26 | 0.28 | 0.31 | 0.33 | 0.36 | 0.39 | 0.42 |
| Dehydroepiandrosterone Sulfate (DHEAS) Test | 0.40 | 0.44 | 0.47 | 0.52 | 0.56 | 0.61 | 0.66 | 0.72 | 0.78 | 0.84 |
| Progesterone Test | 0.60 | 0.65 | 0.71 | 0.77 | 0.84 | 0.91 | 0.99 | 1.07 | 1.17 | 1.27 |
| Testosterone Test | 0.80 | 0.87 | 0.95 | 1.03 | 1.12 | 1.21 | 1.31 | 1.43 | 1.55 | 1.69 |
| Thyroid Stimulating Hormone (TSH) Test | 1.00 | 1.09 | 1.18 | 1.28 | 1.40 | 1.51 | 1.64 | 1.79 | 1.94 | 2.11 |
| Prolactin Test | 1.20 | 1.31 | 1.42 | 1.54 | 1.67 | 1.82 | 1.97 | 2.14 | 2.33 | 2.53 |
| Follicle Stimulating Hormone (FSH) Test | 1.40 | 1.52 | 1.65 | 1.80 | 1.95 | 2.12 | 2.30 | 2.50 | 2.72 | 2.95 |
| Human Chorionic Gonadotropin (hCG) Hormone Test | 1.60 | 1.74 | 1.89 | 2.05 | 2.23 | 2.42 | 2.63 | 2.85 | 3.10 | 3.37 |
| Luteinizing Hormone (LH) Test | 1.80 | 1.96 | 2.13 | 2.31 | 2.51 | 2.72 | 2.96 | 3.21 | 3.49 | 3.79 |
| Cortisol Test | 2.00 | 2.18 | 2.36 | 2.56 | 2.79 | 3.02 | 3.28 | 3.57 | 3.88 | 4.21 |
| Insulin Test | 2.20 | 2.39 | 2.60 | 2.82 | 3.07 | 3.33 | 3.61 | 3.92 | 4.26 | 4.63 |
| Others | 2.40 | 2.61 | 2.83 | 3.08 | 3.34 | 3.63 | 3.94 | 4.28 | 4.64 | 5.05 |
Endocrine Testing Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunoassay | 1.58 | 1.70 | 1.85 | 2.02 | 2.18 | 2.36 | 2.58 | 2.81 | 3.04 | 3.33 |
| Chromatography | 3.13 | 3.40 | 3.70 | 4.02 | 4.34 | 4.72 | 5.15 | 5.57 | 6.05 | 6.55 |
| Mass Spectroscopy | 4.69 | 5.09 | 5.52 | 5.99 | 6.53 | 7.09 | 7.69 | 8.36 | 9.06 | 9.83 |
| Nucleic Acid Based | 6.23 | 6.78 | 7.36 | 7.99 | 8.69 | 9.43 | 10.22 | 11.11 | 12.08 | 13.12 |
Endocrine Testing Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 1.57 | 1.70 | 1.86 | 2.01 | 2.20 | 2.39 | 2.57 | 2.81 | 3.07 | 3.30 |
| Commercial Laboratories | 3.14 | 3.41 | 3.70 | 4.02 | 4.36 | 4.70 | 5.14 | 5.58 | 6.05 | 6.60 |
| Ambulatory Care Centers | 4.68 | 5.09 | 5.52 | 6.00 | 6.49 | 7.10 | 7.70 | 8.34 | 9.04 | 9.83 |
| Others | 6.24 | 6.77 | 7.36 | 7.98 | 8.68 | 9.42 | 10.23 | 11.11 | 12.08 | 13.11 |
Endocrine Testing Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.57 | 1.71 | 1.85 | 2.02 | 2.18 | 2.39 | 2.57 | 2.78 | 3.02 | 3.32 |
| LAMEA | 3.14 | 3.39 | 3.71 | 4.02 | 4.35 | 4.71 | 5.16 | 5.59 | 6.05 | 6.59 |
| Europe | 4.70 | 5.09 | 5.54 | 6.00 | 6.51 | 7.10 | 7.68 | 8.35 | 9.09 | 9.83 |
| Asia-Pacific | 6.23 | 6.79 | 7.35 | 7.99 | 8.69 | 9.41 | 10.23 | 11.12 | 12.09 | 13.11 |
Endocrine Testing Market Size to Hit USD 32.83 Billion by 2034
The global endocrine testing market size accounted for USD 15.63 billion in 2025 and is predicted to touch around USD 32.83 billion by 2034 with a growing at a CAGR of 8.60%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com